Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Groupe Oncologie Radiotherapie Tete et Cou
With
Gustave Roussy, Cancer Campus, Grand Paris
Age
70–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients aged 70 or over
SIOG group 2 (vulnerable)
Life expectancy \> 12 weeks
PS \< 2
Histologically confirmed diagnosis of squamous cell carcinoma of head and neck: oral cavity, oropharynx, nasopharynx, hypopharynx, larynx, cervical nodes (unknown primary).
First line treatment
At least one measurable lesion (RECIST)
Stage II to IV
Patients unsuitable for surgery of the primary tumour: non resectable tumor, anesthesia contra indication, patient's refusal, or organ sparing approach. Cervical nodes dissection authorized
Patients planned to be treated in a curative intent with radiotherapy alone on primary tumor site and on at least one head and neck node area
Consent form signed
You may not be if
Primary squamous cell carcinoma of sinus, the skin or of the salivary glands
Stage I cancer
Radiotherapy planned on primary tumor only, or on neck nodes only. For patients with metastatic lymph nodes from unknown primary head and neck squamous cell carcinoma, patients will be excluded if head and neck mucosa (oropharynx, larynx, hypopharynx) is not included as a target volume for radiotherapy
Prior radiotherapy of head and neck area
Concurrent chemotherapy or immunotherapy or hormonotherapy
Induction chemotherapy
Concomitant infection requiring IV antibiotics
cancer other than head and neck cancer within the previous 5 years (baso cellular skin carcinoma and cervix carcinoma excepted)